Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Rosenstein

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Screening|May 23, 2007
Quality control procedures for dose-response curve generation using nanoliter dispense technologiesCatherine Quintero, Craig Rosenstein, Bethany Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2014
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimizationTony Siu, Sathyajith E Kumarasinghe, Michael D Altman, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2010
The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to leadTony Siu, Ekaterina S Kozina, Joon Jung, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2014
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasmsAndrew M Haidle, Anna A Zabierek, Kaleen K Childers, et al.
Journal of Medicinal Chemistry|September 28, 2011
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disordersJongwon Lim, Brandon Taoka, Ryan D Otte, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymesRobert J Ardecky, Ekaterina V Bobkova, Tina Kiffer-Moreira, et al.
Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.
Journal of Medicinal Chemistry|May 26, 2011
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancerJason D Katz, James P Jewell, David J Guerin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Screening|May 23, 2007
Quality control procedures for dose-response curve generation using nanoliter dispense technologiesCatherine Quintero, Craig Rosenstein, Bethany Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2014
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimizationTony Siu, Sathyajith E Kumarasinghe, Michael D Altman, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2010
The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to leadTony Siu, Ekaterina S Kozina, Joon Jung, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2014
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasmsAndrew M Haidle, Anna A Zabierek, Kaleen K Childers, et al.
Journal of Medicinal Chemistry|September 28, 2011
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disordersJongwon Lim, Brandon Taoka, Ryan D Otte, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymesRobert J Ardecky, Ekaterina V Bobkova, Tina Kiffer-Moreira, et al.
Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.
Journal of Medicinal Chemistry|May 26, 2011
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancerJason D Katz, James P Jewell, David J Guerin, et al.
Pageof 1